| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |